
1298 articles by Nick Paul Taylor
-
Edwards posts 97% success rate with tricuspid device in 30-day test as it prepares for Abbott rival
May 20, 2022 -
Study shows that Abbott's Amulet, Boston Scientific's Watchman devices are riskier for women
May 19, 2022 -
Medtronic links renal denervation to increased time below blood-pressure threshold
May 18, 2022 -
LabCorp becomes first company to get EUA for direct-to-consumer test for flu, RSV, COVID-19
May 18, 2022 -
FDA posts Class I recall report for 51,000 rapid antigen COVID-19 tests
May 16, 2022 -
FDA needs testing enforcement discretion policy to improve crisis response, GAO finds
May 13, 2022 -
Hologic gets FDA approval to challenge Abbott, Roche in transplant testing market
May 12, 2022 -
Medtronic completes Intersect acquisition following FTC order
May 11, 2022 -
Rising Google searches for procedures suggest recovering demand at medtechs: analysts
May 11, 2022 -
FDA finalizes guidance on clinical feasibility studies of diabetic glycemic control devices
May 9, 2022 -
EU task force posts guidance on significant IVDR changes to address a top priority for industry
May 6, 2022 -
FDA reveals another Class I COVID-19 test recall as SML pulls 209,000 kits from the market
May 5, 2022 -
FDA clears Abbott's 4-in-1 Alinity PCR test for sexually transmitted infections
May 5, 2022 -
Biden should send 'clear' message to semiconductor industry on prioritizing medtech, AdvaMed says
May 4, 2022 -
Boston Scientific's Watchman FLX shows higher success rate than predecessor, boosting Abbott rivalry
May 4, 2022 -
Hologic, Thermo Fisher, Qiagen quarterly sales beat estimates on COVID-19 test revenue
May 3, 2022 -
FDA labels Celltrion's latest recall of 310,000 COVID-19 tests as a Class I event
May 2, 2022 -
ACLA, AdvaMed urge Congress to immediately replenish COVID-19 testing fund
April 28, 2022 -
HHS inspector general rules physician-owned device company poses a low risk of fraud and abuse
April 26, 2022 -
Philips commits more cash to recall as DOJ issues subpoena
April 25, 2022 -
FDA warns about noninvasive prenatal tests, but analysts see minimal industry impact
April 22, 2022 -
Medtech survey finds widespread cybersecurity noncompliance despite rising investment
April 21, 2022 -
Persistent procedure backlogs point to boost for Stryker and Zimmer: analysts
April 21, 2022 -
Philips investigates reports of 1 death, 4 injuries potentially tied to ventilator recall
April 20, 2022 -
FDA authorizes first COVID-19 breathalyzer test, clearing path to 3-minute results
April 18, 2022